Source: Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018



Rating:

Share or cite this content

Citations should be made in the following way:
Hafez Al Momani, Audrey Perry, Rhys Jones, Melissa McDonnell, Amaran Krishnan, Andrew Robertson, Mike Griffin, Robert Rutherford, Malcolm Brodlie, Jeff Pearson, Steve Bourke, Chris Ward. Risk factors for lung disease progression in children with cystic fibrosis. Eur Respir J, 52 (4) 1801492; 10.1183/13993003.01492-2018

Member's Comments

No comment yet.

Related content which might interest you: Risk factors for progression of cystic fibrosis lung disease from childhood to adulthood Source: Virtual Congress 2020 – Respiratory diseases in children and adults Year: 2020 Factors affecting progression of lung disease among patients with cystic fibrosis Source: International Congress 2019 – Physiology of cystic fibrosis Year: 2019 Early determinants of lung disease in children with cystic fibrosis Source: Virtual Congress 2020 – New frontiers in cystic fibrosis imaging and lung physiology Year: 2020 Risk factors for lung disease progression in children with cystic fibrosis; a longitudinal cohort study Source: International Congress 2017 – Cystic fibrosis: treatments and monitoring Year: 2017 Screening for cystic fibrosis among high risk group patients with chronic lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 340s Year: 2002 Relations between the sinonasal development and the lung disease in cystic fibrosis patients Source: Eur Respir J 2005; 26: Suppl. 49, 103s Year: 2005 Prevalence, risk factors and prognosis of pulmonary hypertension in cystic fibrosis Source: Annual Congress 2011 - Cystic fibrosis: new basic, clinical and bacteriological knowledge Year: 2011 Elucidating progression of early cystic fibrosis lung disease Source: Eur Respir J, 50 (5) 1701916; 10.1183/13993003.01916-2017 Year: 2017 Season dynamics of inflammatory markers in patients with cystic fibrosis lung disease Source: Eur Respir J 2002; 20: Suppl. 38, 528s Year: 2002 Early cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 77-87 Year: 2014 Incidence and predictive factors of lung cancer in patients with idiopathic pulmonary fibrosis Source: ERJ Open Res, 4 (1) 00111-2016; 10.1183/23120541.00111-2016 Year: 2018 Questions of predicting and preventing the progression of pneumofibrosis in children with cystic fibrosis Source: International Congress 2019 – Infection and inflammation in cystic fibrosis Year: 2019 Efficacy of elexacaftor/tezacaftor/ivacaftor in patients with cystic fibrosis and advanced lung disease Source: Eur Respir J, 57 (2) 2003079; 10.1183/13993003.03079-2020 Year: 2021 Predictive factors of lung function decline in adults with cystic fibrosis Source: Eur Respir J 2006; 28: Suppl. 50, 714s Year: 2006 Comorbidities of advanced diseases in patients with cystic fibrosis Source: Virtual Congress 2020 – Cystic fibrosis: from cradle to old age Year: 2020 Pathophysiology of cystic fibrosis lung disease Source: Eur Respir Monogr 2014; 64: 1-13 Year: 2014 Lung function in children with cystic fibrosis liver disease Source: Virtual Congress 2021 – Cystic fibrosis in children: various aspects Year: 2021 Biomarkers of early relapse of pulmonary exacerbation in cystic fibrosis adult patients Source: Annual Congress 2013 –Cystic fibrosis: clinical problems and microbiology in adults Year: 2013